SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Maxine S. Jochelson, Elizabeth A. Morris, An Imaging Approach to High-Risk Screening for Breast Cancer, Seminars in Roentgenology, 2011, 46, 1, 68

    CrossRef

  2. 2
    Wendy S. Rubinstein, Louise S. Acheson, Suzanne M. OʼNeill, Mack T. Ruffin, Catharine Wang, Jennifer L. Beaumont, Nan Rothrock, Clinical utility of family history for cancer screening and referral in primary care: A report from the Family Healthware Impact Trial, Genetics in Medicine, 2011, 13, 11, 956

    CrossRef

  3. 3
    E. Warner, Impact of MRI surveillance and breast cancer detection in young women with BRCA mutations, Annals of Oncology, 2011, 22, Supplement 1, i44

    CrossRef

  4. 4
    Ellen Warner, Petrina A. Causer, John W-N. Wong, Frances C. Wright, Roberta A. Jong, Kimberley A. Hill, Sandra J. Messner, Martin J. Yaffe, Steven A. Narod, Donald B. Plewes, Improvement in DCIS Detection Rates by MRI Over Time in a High-Risk Breast Screening Study, The Breast Journal, 2011, 17, 1
  5. 5
    Ayodele Ayoola, Suganthi Alagarsamy, Jerry Jaboin, Suman Rao, Increase in Mastectomies Performed in Patients in the Community Setting Undergoing MRI, The Breast Journal, 2011, 17, 3
  6. 6
    Debra L. Monticciolo, Magnetic Resonance Imaging of the Breast for Cancer Diagnosis and Staging, Seminars in Ultrasound, CT, and MRI, 2011, 32, 4, 319

    CrossRef

  7. 7
    Steven A. Narod, Screening of women at high risk for breast cancer, Preventive Medicine, 2011, 53, 3, 127

    CrossRef

  8. 8
    Steven A. Narod, BRCA mutations in the management of breast cancer: the state of the art, Nature Reviews Clinical Oncology, 2010, 7, 12, 702

    CrossRef

  9. 9
    Elisabeth Chéreau, Catherine Uzan, Corinne Balleyguier, Julie Chevalier, Brigitte Bressac de Paillerets, Olivier Caron, Françoise Rimareix, Marie-Christine Mathieu, Martin Koskas, Céline Bourgier, Fabrice André, Clarisse Dromain, Suzette Delaloge, Characteristics, Treatment, and Outcome of Breast Cancers Diagnosed in <i>BRCA1</i> and <i>BRCA2</i> Gene Mutation Carriers in Intensive Screening Programs Including Magnetic Resonance Imaging, Clinical Breast Cancer, 2010, 10, 2, 113

    CrossRef

  10. 10
    B. A. Virnig, S.-Y. Wang, T. Shamilyan, R. L. Kane, T. M. Tuttle, Ductal Carcinoma In Situ: Risk Factors and Impact of Screening, JNCI Monographs, 2010, 2010, 41, 113

    CrossRef

  11. 11
    Sandhya Pruthi, Bobbie S. Gostout, Noralane M. Lindor, Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer, Mayo Clinic Proceedings, 2010, 85, 12, 1111

    CrossRef

  12. 12
    K. P. M. Suijkerbuijk, P. J. van Diest, E. van der Wall, Improving early breast cancer detection: focus on methylation, Annals of Oncology, 2010, 22, 1, 24

    CrossRef

  13. 13
    C.C. Riedl, L. Ponhold, R. Gruber, K. Pinker, T.H. Helbich, Neues zum Hochrisikomammascreening, Der Radiologe, 2010, 50, 11, 955

    CrossRef

  14. 14
    Edward A. Sickles, The Use of Breast Imaging to Screen Women at High Risk for Cancer, Radiologic Clinics of North America, 2010, 48, 5, 859

    CrossRef

  15. 15
    William D. Foulkes, Jorge S. Reis-Filho, Steven A. Narod, Tumor size and survival in breast cancer—a reappraisal, Nature Reviews Clinical Oncology, 2010, 7, 6, 348

    CrossRef

  16. 16
    Basak E. Dogan, Wei Tse Yang, Why Is Breast MRI so Controversial?, Current Breast Cancer Reports, 2010, 2, 3, 159

    CrossRef

  17. 17
    Inge-Marie A. Obdeijn, Claudette E. Loo, Adriana J. Rijnsburger, Martin N. J. M. Wasser, Elisabeth Bergers, Theo Kok, Jan G. M. Klijn, Carla Boetes, Assessment of false-negative cases of breast MR imaging in women with a familial or genetic predisposition, Breast Cancer Research and Treatment, 2009, 119, 2, 399

    CrossRef

  18. 18
    M. Lapierre-Combes, J. Rousset, E. Combes, S. Chinelatto, P.-F. Dupré, V. André, Étude rétrospective dans le Nord-Finistère sur la place de l’IRM mammaire devant un bilan sénologique normal, à propos de 51 cas, Gynécologie Obstétrique & Fertilité, 2009, 37, 5, 401

    CrossRef

  19. 19
    Martin O. Leach, Breast cancer screening in women at high risk using MRI, NMR in Biomedicine, 2009, 22, 1
  20. 20
    Charu Taneja, John Edelsberg, Derek Weycker, Amy Guo, Gerry Oster, Jeffrey Weinreb, Cost Effectiveness of Breast Cancer Screening With Contrast-Enhanced MRI in High-Risk Women, Journal of the American College of Radiology, 2009, 6, 3, 171

    CrossRef

  21. 21
    Janie M. Lee, Elkan F. Halpern, Elizabeth A. Rafferty, G. Scott Gazelle, Evaluating the Correlation between Film Mammography and MRI for Screening Women with Increased Breast Cancer Risk, Academic Radiology, 2009, 16, 11, 1323

    CrossRef

  22. 22
    Edibaldo Silva, Targeted Tailored Management of the Breast Cancer Patient at Risk for Harboring a Germline Mutation—Current Trends Affecting the Selection of Patients Considering Surgical Prophylaxis for Breast Cancer, The Breast Journal, 2009, 15,
  23. 23
    Tirtza N. Spiegel, Kimberley A. Hill, Ellen Warner, The Attitudes of Women with BRCA1 and BRCA2 Mutations toward Clinical Breast Examinations and Breast Self-Examinations, Journal of Women's Health, 2009, 18, 7, 1019

    CrossRef

  24. 24
    Alan B. Hollingsworth, Rebecca G. Stough, Breast MRI Screening for High-Risk Patients, Seminars in Breast Disease, 2008, 11, 2, 67

    CrossRef

  25. 25
    J. Veltman, R. Mann, T. Kok, I. M. Obdeijn, N. Hoogerbrugge, J. G. Blickman, C. Boetes, Breast tumor characteristics of BRCA1 and BRCA2 gene mutation carriers on MRI, European Radiology, 2008, 18, 5, 931

    CrossRef

  26. 26
    E. Daguet, C. Malhaire, C. Hardit, A. Athanasiou, C. El Khoury, F. Thibault, L. Ollivier, A. Tardivon, A. Tardivon, Dépistage du cancer du sein par IRM chez les femmes porteuses d’une mutation génétique, Journal de Radiologie, 2008, 89, 6, 783

    CrossRef

  27. You have free access to this content27
    Edibaldo Silva, Zoran Gatalica, Carrie Snyder, Semir Vranic, Jane F. Lynch, Henry T. Lynch, Hereditary Breast Cancer: Part II. Management of Hereditary Breast Cancer: Implications of Molecular Genetics and Pathology, The Breast Journal, 2008, 14, 1
  28. 28
    Allison W. Kurian, Anne-Renee Hartman, Meredith A. Mills, Laura J. Logan, Anne Marie Sawyer, James M. Ford, Bruce L. Daniel, Magnetic Resonance Galactography: a Feasibility Study in Women with Prior Atypical Breast Duct Cytology, The Breast Journal, 2008, 14, 2
  29. 29
    Elon J. Granader, Ben Dwamena, Ruth C. Carlos, MRI and Mammography Surveillance of Women at Increased Risk for Breast Cancer, Academic Radiology, 2008, 15, 12, 1590

    CrossRef

  30. 30
    Antonio Millet Serrano, Bienvenido Leal Llorca, Antonio Leal Benavent, Resonancia magnética y cáncer mamario contralateral, Progresos de Obstetricia y Ginecología, 2008, 51, 4, 232

    CrossRef

  31. 31
    R. Kaas, S.H. Muller, A.A.M. Hart, E.J.T. Rutgers, Stage of breast cancers found during the surveillance of women with a familial or hereditary risk, European Journal of Surgical Oncology (EJSO), 2008, 34, 5, 501

    CrossRef

  32. 32
    Colleen D. Murphy, Janie M. Lee, Brian Drohan, David M. Euhus, Daniel B. Kopans, Michele A. Gadd, Elizabeth A. Rafferty, Michelle C. Specht, Barbara L. Smith, Kevin S. Hughes, The American Cancer Society guidelines for breast screening with magnetic resonance imaging, Cancer, 2008, 113, 11
  33. 33
    Ellen Warner, The Role of Magnetic Resonance Imaging in Screening Women at High Risk of Breast Cancer, Topics in Magnetic Resonance Imaging, 2008, 19, 3, 163

    CrossRef

  34. 34
    Edibaldo Silva, Genetic counseling and clinical management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations: perspective of a surgical oncologist, Familial Cancer, 2007, 7, 1, 91

    CrossRef

  35. 35
    Dimitrios H Roukos, Evangelos Briasoulis, Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome, Nature Clinical Practice Oncology, 2007, 4, 10, 578

    CrossRef

  36. 36
    Wei-Tse Yang, Mark Dryden, Kristine Broglio, Michael Gilcrease, Shaheenah Dawood, Peter J. Dempsey, Vicente Valero, Gabriel Hortobagyi, Deann Atchley, Banu Arun, Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women, Breast Cancer Research and Treatment, 2007, 111, 3, 405

    CrossRef

  37. 37
    Catherine Colin, Violaine Prince, Modalités de dépistage radiologique devant un risque familial identifié de cancer du sein, Imagerie de la Femme, 2007, 17, 3, 161

    CrossRef

  38. 38
    Rebecca Dent, Ellen Warner, Screening for Hereditary Breast Cancer, Seminars in Oncology, 2007, 34, 5, 392

    CrossRef

  39. 39
    Anne I. Hagen, Kjell Arne Kvistad, Lovise Maehle, Marit Muri Holmen, Hildegunn Aase, Bodil Styr, Anita Vabø, Jaran Apold, Per Skaane, Pål Møller, Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series, The Breast, 2007, 16, 4, 367

    CrossRef

  40. 40
    Michael Fatouros, Georgios Baltoyiannis, Dimitrios H. Roukos, The Predominant Role of Surgery in the Prevention and New Trends in the Surgical Treatment of Women With BRCA1/2 Mutations, Annals of Surgical Oncology, 2007, 15, 1, 21

    CrossRef

  41. 41
    S.A. Feig, 4–8 A Basal Epithelial Phenotype Is More Frequent in Interval Breast Cancers Compared With Screen Detected Tumors, Breast Diseases: A Year Book Quarterly, 2006, 16, 4, 337

    CrossRef

  42. 42
    Mieke Kriege, Cecile T. M. Brekelmans, Inge Marie Obdeijn, Carla Boetes, Harmine M. Zonderland, Sara H. Muller, Theo Kok, Radu A. Manoliu, A. Peter E. Besnard, Madeleine M. A. Tilanus-Linthorst, Caroline Seynaeve, Carina C. M. Bartels, Reini Kaas, Siebren Meijer, Jan C. Oosterwijk, Nicoline Hoogerbrugge, Rob A. E. M. Tollenaar, Emiel J. T. Rutgers, Harry J. Koning, Jan G. M. Klijn, Factors Affecting Sensitivity and Specificity of Screening Mammography and MRI in Women with an Inherited Risk for Breast Cancer, Breast Cancer Research and Treatment, 2006, 100, 1, 109

    CrossRef

  43. 43
    John Benson, Is screening mammography safe for high-risk patients?, The Lancet Oncology, 2006, 7, 5, 360

    CrossRef

  44. 44
    Christiane K. Kuhl, MR Imaging for Surveillance of Women at High Familial Risk for Breast Cancer, Magnetic Resonance Imaging Clinics of North America, 2006, 14, 3, 391

    CrossRef

  45. 45
    Stephanie M. Estala, Proposed Screening Recommendations for Male Breast Cancer, The Nurse Practitioner, 2006, 31, 2, 62

    CrossRef

  46. 46
    C.K. Kuhl, W. Kuhn, H. Schild, Management of women at high risk for breast cancer: New imaging beyond mammography, The Breast, 2005, 14, 6, 480

    CrossRef

  47. 47
    Ellen Warner, Petrina A Causer, MRI surveillance for hereditary breast-cancer risk, The Lancet, 2005, 365, 9473, 1747

    CrossRef

  48. 48
    M. S. Frech, L. P. Jones, P. A. Furth, Validation of transgenic models of breast cancer: ductal carcinoma in situ (DCIS) and Brca1-mutation-related breast cancer, Breast Cancer Online, 2005, 8, 08

    CrossRef

  49. 49
    Laura Liberman, Breast Cancer Screening with MRI — What Are the Data for Patients at High Risk?, New England Journal of Medicine, 2004, 351, 5, 497

    CrossRef

  50. 50
    Maureen A. Chung, Blake Cady, Surgical Treatment Planning in Newly Diagnosed Breast Cancer Patients at High Risk for BRCA-1 or BRCA-2 Mutation, The Breast Journal, 2004, 10, 6